Bottom line
SQBAX vs VEIRX: the short answer
SQBAX (Investment Quality Bond Portfolio) and VEIRX (Vanguard Equity Income Fund) are both mutual funds.
But VEIRX is far broader, holding 232 positions to 3 for SQBAX, so beyond the top names it adds exposure SQBAX doesn't have.
VEIRX is cheaper at 0.17% vs 2.22% — a difference of $205 a year per $10,000 invested.
Over five years, VEIRX returned +12.8% a year vs −1.0% for SQBAX (reporting dates differ).
SQBAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
SQBAX vs VEIRX side by side
| SQBAX | VEIRX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Saratoga Advantage | Vanguard |
| Category | Core / Intermediate Bond | Core / Intermediate Bond |
| Expense ratio | 2.22% | 0.17% |
| Annual cost per $10k | $222 | $17 |
| 10-yr cost on $10k (prospectus) | $2,982 | $217 |
| Max front load | 5.75% | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | −5.3% | +17.2% |
| 5-yr return (annualized) | −1.0% | +12.8% |
| 10-yr return (annualized) | −0.2% | +11.7% |
| Best quarter | +4.2% | — |
| Worst quarter | −2.9% | — |
| Net assets (fund) | $7.8M | $65.5B |
| Number of holdings | 3 | 232 |
| Portfolio turnover | 29% | 51% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
SQBAX and VEIRX share none of their top holdings.
SQBAX top 10
- Vanguard Index Funds — 92.13%
- Vanguard Index Funds — 4.80%
- Dreyfus Institutional Preferred Money Market Funds — 3.22%
VEIRX top 10
- Broadcom Inc — 8.03%
- Merck & Co Inc — 2.43%
- Johnson & Johnson — 2.28%
- Bank of America Corp — 2.18%
- Diamondback Energy Inc — 1.89%
- Cisco Systems Inc — 1.46%
- Huntington Bancshares Inc/OH — 1.34%
- Walt Disney Co/The — 1.31%
- M&T Bank Corp — 1.30%
- Unilever PLC — 1.27%
FAQ
What is the difference between SQBAX and VEIRX?
Which is cheaper, SQBAX or VEIRX?
Should I own both SQBAX and VEIRX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.